Comparing proteomics to genomics reveals essential insights into their contributions to systems biology and experimental ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Life on Earth began simply. For billions of years, tiny microbes ruled the planet. Then, one day in deep time, something changed. Cells gained a nucleus, built inner compartments and learned to ...

Despite their readiness, blood centres remain an underutilised lever in pharma’s innovation model. As industry players seek ...

In June 2024, Resolution Therapeutics, in collaboration with the University of Edinburgh, presented pivotal RTX001 data at ...

A tiny bacterium, Tersicoccus phoenicis, is changing how scientists view cleanliness in secure areas. This microbe survives ...

AlidaBio today announced the launch of the EpiPlex™ Duo-Mod™ Service, a turnkey offering that maps and quantifies ...

The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the formation of biomolecular condensates, "droplets" of concentrated proteins, DNA ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

New fixation method streamlines blood sample handling for translational researchSEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing ...

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...